Tomasz Skorski

Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile.

Curt I Civin, Kara Scheibner, Tomasz Sliwinski, 2013, Blood.

Multilevel Dysregulation of STAT3 Activation in Anaplastic Lymphoma Kinase-Positive T/Null-Cell Lymphoma1

Qian Zhang, M. Wasik, T. Skorski, 2002, The Journal of Immunology.

PARP1 inhibitor olaparib (Lynparza) exerts synthetic lethal effect against ligase 4-deficient melanomas

Reinhard Dummer, Kinga Majchrzak, Tomasz Sliwinski, 2016, Oncotarget.

Oncogenic tyrosine kinases and the dna-damage response

T. Skorski, Tomasz Skorski, 2002, Nature Reviews Cancer.

BCR/ABL inhibits mismatch repair to protect from apoptosis and induce point mutations.

Janusz Blasiak, Tomasz Poplawski, T. Skorski, 2008, Cancer research.

BCR/ABL regulates response to DNA damage: the role in resistance to genotoxic treatment and in genomic instability

T. Skorski, Tomasz Skorski, 2002, Oncogene.